+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Dyspnea Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • PDF Icon

    Report

  • 150 Pages
  • April 2019
  • Region: Global
  • VPA Research
  • ID: 4767408
The global clinical trial report- “2019 Dyspnea Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Dyspnea. It presents in-depth analysis of Dyspnea clinical trials across markets and companies. The research work is for providing complete understanding into trends in Dyspnea.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Dyspnea clinical trials by:
  • Current Trial Status

  • Type of the trial

  • Sponsor Type

  • Enrollment Trends

  • Region

  • Countries

  • Trial Phase



The report also identifies the potential drug candidates under development for treatment of Dyspnea

The research work is prepared through extensive and continuous research on Dyspnea trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.

  • Drug candidates currently being researched for administering Dyspnea patients are identified

  • The report includes panorama of Dyspnea clinical trials across the globe

  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided

  • Companies and universities focusing on Dyspnea clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)

  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included

  • Both interventional and observational studies are analyzed

  • News and latest developments for the past one year are presented in the report

Table of Contents

1.1 List of Figures1.2 List of Tables
2. Executive Summary
2.1 Dyspnea Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Dyspnea Clinical Trials by Region
2.2.2 Average Enrollment of Dyspnea Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Dyspnea Treatment, 2019
3. Region wise Dyspnea Clinical Trials
3.1 Asia Pacific Dyspnea Clinical Trials by Country
3.2 Europe Dyspnea Clinical Trials by Country
3.3 North America Dyspnea Clinical Trials by Country
3.4 Middle East and Africa Dyspnea Clinical Trials by Country
3.5 South and Central America Dyspnea Clinical Trials by Country
4. Dyspnea Clinical Trial Trends
4.1 Start Year wise Dyspnea Clinical Trials
4.2 Phase wise Dyspnea Clinical Trials
4.3 Trial Status wise Dyspnea Clinical Trials
4.4 Trial Type wise Dyspnea Clinical Trials
5. Dyspnea Average Enrollment Trends
5.1 Average Enrollment in Dyspnea Trials by Year
5.2 Average Enrollment in Dyspnea Trials by Phase
5.3 Average Enrollment in Dyspnea Trials by Status
5.4 Average Enrollment in Dyspnea Trials by Type of Trial
6. Companies Participating in Dyspnea Clinical Trials
6.1 Dyspnea Trials by Sponsor Type
6.2 Dyspnea Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Dyspnea Trials- Phase 1
7.2 Dyspnea Trials- Phase 2
7.3 Dyspnea Trials- Phase 3
7.4 Dyspnea Trials- Phase 4
8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
List of Figures
Figure 1: Dyspnea Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Dyspnea Clinical Trials and Enrolment
Figure 5: Europe - Country wise Dyspnea Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Dyspnea Clinical Trials and Enrolment
Figure 7: North America - Country wise Dyspnea Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Dyspnea Clinical Trials and Enrolment
Figure 9: Dyspnea Clinical Trials by Phase
Figure 10: Dyspnea Clinical Trials by Trial Status
Figure 11: Dyspnea Clinical Trials by Type
Figure 12: Dyspnea Clinical Trials by Sponsor Type
Figure 13: Dyspnea Clinical Trials by Leading Sponsors
Figure 14: Dyspnea Average Enrollment by Phase
Figure 15: Dyspnea Average Enrollment by Trial Status
Figure 16: Dyspnea Average Enrollment by Type
Figure 17: Dyspnea- Average Enrolment by Type of Sponsors
Figure 18: Dyspnea- Enrolment by Leading Sponsors
Figure 19: Research Methodology
List of Tables
Table 1: Dyspnea Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Dyspnea Clinical Trials and Enrolment
Table 5: Europe - Country wise Dyspnea Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Dyspnea Clinical Trials and Enrolment
Table 7: North America - Country wise Dyspnea Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Dyspnea Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Dyspnea Average Enrollment by Phase
Table 15: Dyspnea Average Enrollment by Trial Status
Table 16: Dyspnea Average Enrollment by Type
Table 17: Dyspnea- Average Enrolment by Type of Sponsors
Table 18: Dyspnea- Enrolment by Leading Sponsors

Companies Mentioned

  • 3M Drug Delivery Systems

  • Abbott Laboratories

  • Amphastar Pharmaceuticals Inc

  • AstraZeneca Plc

  • Atlantic Health Sciences Corp

  • C. H. Boehringer Sohn AG & Co KG

  • GlaxoSmithKline Plc

  • Johnson & Johnson

  • Novartis AG

  • Teva Pharmaceutical Industries Ltd